The global Genome Editing and Genome Engineering market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Genome editing technology refers to the ability of human to "edit" the target gene, such as the deletion and addition of specific DNA fragments.
The report includes an overview of the development of the Genome Editing and Genome Engineering industry chain, the market status of Cell Line Engineering (CRISPR, TALEN), Animal Genetic Engineering (CRISPR, TALEN), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Genome Editing and Genome Engineering.
Regionally, the report analyzes the Genome Editing and Genome Engineering markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Genome Editing and Genome Engineering market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Genome Editing and Genome Engineering market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Genome Editing and Genome Engineering industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CRISPR, TALEN).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Genome Editing and Genome Engineering market.
Regional Analysis: The report involves examining the Genome Editing and Genome Engineering market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Genome Editing and Genome Engineering market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Genome Editing and Genome Engineering:
Company Analysis: Report covers individual Genome Editing and Genome Engineering players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Genome Editing and Genome Engineering This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cell Line Engineering, Animal Genetic Engineering).
Technology Analysis: Report covers specific technologies relevant to Genome Editing and Genome Engineering. It assesses the current state, advancements, and potential future developments in Genome Editing and Genome Engineering areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Genome Editing and Genome Engineering market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Genome Editing and Genome Engineering market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
CRISPR
TALEN
ZFN
麻豆原创 segment by Application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others
麻豆原创 segment by players, this report covers
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated DNA Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Tecan Life Sciences
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Genome Editing and Genome Engineering product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Genome Editing and Genome Engineering, with revenue, gross margin and global market share of Genome Editing and Genome Engineering from 2019 to 2024.
Chapter 3, the Genome Editing and Genome Engineering competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Genome Editing and Genome Engineering market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genome Editing and Genome Engineering.
Chapter 13, to describe Genome Editing and Genome Engineering research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Genome Editing and Genome Engineering
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Genome Editing and Genome Engineering by Type
1.3.1 Overview: Global Genome Editing and Genome Engineering 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Genome Editing and Genome Engineering Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 CRISPR
1.3.4 TALEN
1.3.5 ZFN
1.4 Global Genome Editing and Genome Engineering 麻豆原创 by Application
1.4.1 Overview: Global Genome Editing and Genome Engineering 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cell Line Engineering
1.4.3 Animal Genetic Engineering
1.4.4 Plant Genetic Engineering
1.4.5 Others
1.5 Global Genome Editing and Genome Engineering 麻豆原创 Size & Forecast
1.6 Global Genome Editing and Genome Engineering 麻豆原创 Size and Forecast by Region
1.6.1 Global Genome Editing and Genome Engineering 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Genome Editing and Genome Engineering 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Genome Editing and Genome Engineering 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Genome Editing and Genome Engineering 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Genome Editing and Genome Engineering 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Genome Editing and Genome Engineering 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Genome Editing and Genome Engineering 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Genome Editing and Genome Engineering Product and Solutions
2.1.4 Thermo Fisher Scientific Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Genome Editing and Genome Engineering Product and Solutions
2.2.4 Merck Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Merck Recent Developments and Future Plans
2.3 Horizon Discovery
2.3.1 Horizon Discovery Details
2.3.2 Horizon Discovery Major Business
2.3.3 Horizon Discovery Genome Editing and Genome Engineering Product and Solutions
2.3.4 Horizon Discovery Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Horizon Discovery Recent Developments and Future Plans
2.4 Genscript
2.4.1 Genscript Details
2.4.2 Genscript Major Business
2.4.3 Genscript Genome Editing and Genome Engineering Product and Solutions
2.4.4 Genscript Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Genscript Recent Developments and Future Plans
2.5 Sangamo Biosciences
2.5.1 Sangamo Biosciences Details
2.5.2 Sangamo Biosciences Major Business
2.5.3 Sangamo Biosciences Genome Editing and Genome Engineering Product and Solutions
2.5.4 Sangamo Biosciences Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Sangamo Biosciences Recent Developments and Future Plans
2.6 Integrated DNA Technologies
2.6.1 Integrated DNA Technologies Details
2.6.2 Integrated DNA Technologies Major Business
2.6.3 Integrated DNA Technologies Genome Editing and Genome Engineering Product and Solutions
2.6.4 Integrated DNA Technologies Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Integrated DNA Technologies Recent Developments and Future Plans
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business
2.7.3 Lonza Genome Editing and Genome Engineering Product and Solutions
2.7.4 Lonza Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Lonza Recent Developments and Future Plans
2.8 New England Biolabs
2.8.1 New England Biolabs Details
2.8.2 New England Biolabs Major Business
2.8.3 New England Biolabs Genome Editing and Genome Engineering Product and Solutions
2.8.4 New England Biolabs Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 New England Biolabs Recent Developments and Future Plans
2.9 Origene Technologies
2.9.1 Origene Technologies Details
2.9.2 Origene Technologies Major Business
2.9.3 Origene Technologies Genome Editing and Genome Engineering Product and Solutions
2.9.4 Origene Technologies Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Origene Technologies Recent Developments and Future Plans
2.10 Transposagen Biopharmaceuticals
2.10.1 Transposagen Biopharmaceuticals Details
2.10.2 Transposagen Biopharmaceuticals Major Business
2.10.3 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Product and Solutions
2.10.4 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Transposagen Biopharmaceuticals Recent Developments and Future Plans
2.11 Editas Medicine
2.11.1 Editas Medicine Details
2.11.2 Editas Medicine Major Business
2.11.3 Editas Medicine Genome Editing and Genome Engineering Product and Solutions
2.11.4 Editas Medicine Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Editas Medicine Recent Developments and Future Plans
2.12 Crispr Therapeutics
2.12.1 Crispr Therapeutics Details
2.12.2 Crispr Therapeutics Major Business
2.12.3 Crispr Therapeutics Genome Editing and Genome Engineering Product and Solutions
2.12.4 Crispr Therapeutics Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Crispr Therapeutics Recent Developments and Future Plans
2.13 Tecan Life Sciences
2.13.1 Tecan Life Sciences Details
2.13.2 Tecan Life Sciences Major Business
2.13.3 Tecan Life Sciences Genome Editing and Genome Engineering Product and Solutions
2.13.4 Tecan Life Sciences Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Tecan Life Sciences Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Genome Editing and Genome Engineering Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Genome Editing and Genome Engineering by Company Revenue
3.2.2 Top 3 Genome Editing and Genome Engineering Players 麻豆原创 Share in 2023
3.2.3 Top 6 Genome Editing and Genome Engineering Players 麻豆原创 Share in 2023
3.3 Genome Editing and Genome Engineering 麻豆原创: Overall Company Footprint Analysis
3.3.1 Genome Editing and Genome Engineering 麻豆原创: Region Footprint
3.3.2 Genome Editing and Genome Engineering 麻豆原创: Company Product Type Footprint
3.3.3 Genome Editing and Genome Engineering 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Genome Editing and Genome Engineering Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Genome Editing and Genome Engineering 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Genome Editing and Genome Engineering Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Genome Editing and Genome Engineering 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Genome Editing and Genome Engineering Consumption Value by Type (2019-2030)
6.2 North America Genome Editing and Genome Engineering Consumption Value by Application (2019-2030)
6.3 North America Genome Editing and Genome Engineering 麻豆原创 Size by Country
6.3.1 North America Genome Editing and Genome Engineering Consumption Value by Country (2019-2030)
6.3.2 United States Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Genome Editing and Genome Engineering Consumption Value by Type (2019-2030)
7.2 Europe Genome Editing and Genome Engineering Consumption Value by Application (2019-2030)
7.3 Europe Genome Editing and Genome Engineering 麻豆原创 Size by Country
7.3.1 Europe Genome Editing and Genome Engineering Consumption Value by Country (2019-2030)
7.3.2 Germany Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Genome Editing and Genome Engineering Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Genome Editing and Genome Engineering Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Genome Editing and Genome Engineering 麻豆原创 Size by Region
8.3.1 Asia-Pacific Genome Editing and Genome Engineering Consumption Value by Region (2019-2030)
8.3.2 China Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Genome Editing and Genome Engineering Consumption Value by Type (2019-2030)
9.2 South America Genome Editing and Genome Engineering Consumption Value by Application (2019-2030)
9.3 South America Genome Editing and Genome Engineering 麻豆原创 Size by Country
9.3.1 South America Genome Editing and Genome Engineering Consumption Value by Country (2019-2030)
9.3.2 Brazil Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Genome Editing and Genome Engineering Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Genome Editing and Genome Engineering Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Genome Editing and Genome Engineering 麻豆原创 Size by Country
10.3.1 Middle East & Africa Genome Editing and Genome Engineering Consumption Value by Country (2019-2030)
10.3.2 Turkey Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Genome Editing and Genome Engineering 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Genome Editing and Genome Engineering 麻豆原创 Drivers
11.2 Genome Editing and Genome Engineering 麻豆原创 Restraints
11.3 Genome Editing and Genome Engineering Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Genome Editing and Genome Engineering Industry Chain
12.2 Genome Editing and Genome Engineering Upstream Analysis
12.3 Genome Editing and Genome Engineering Midstream Analysis
12.4 Genome Editing and Genome Engineering Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated DNA Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Tecan Life Sciences
听
听
*If Applicable.
